QA: Abbott Laboratories in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2012_Abbott_Laboratories.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 23,768,774,000
1 IntangibleAssetsNetIncludingGoodwill 25,695,016,000
2 PropertyPlantAndEquipmentNet 7,873,955,000
3 remainder_Assets 2,939,148,000
4 LiabilitiesCurrent 15,480,228,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,756,817,000
9 ResearchAndDevelopmentExpense 4,801,914,000
10 remainder_Expenses 16,540,914,000
11 remainder_Revenues 38,851,259,000
12 remainder_NetIncome -23,165,000
13 remainder_ComprehensiveNetIncome -1,230,339,000
  yvar yval
0 Assets 60,276,893,000
1 Liabilities 15,480,228,000
2 Expenses 34,099,645,000
3 Revenues 38,851,259,000
4 StockholdersEquity 44,796,665,000
5 NetIncome 4,728,449,000
6 ComprehensiveNetIncome 4,113,279,500
7 BaseVar 74,980,764,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.69
9 EconomicCapitalRatio 3.48

Edgar->Model Mapping

Feature Distribution

Change over Time